The number of people starting treatment for ketamine addiction in 2023-24 was 3609 – over 8 times higher than the 426 reported in 2014-15. But neither ICD-11 nor DSM-5 include ketamine specific criteria for dependence or withdrawal, or thresholds for clinically relevant harm, King’s College London et al explain.